Recurrent Disease Active Not Recruiting Phase 1 Trials for Temozolomide (DB00853)

IndicationStatusPhase
DBCOND0028541 (Recurrent Disease)Active Not Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01139970Veliparib and Temozolomide in Treating Patients With Acute LeukemiaTreatment